Rock Springs Capital Management Lp - Net Worth and Insider Trading

Over the past 18 months, Rock Springs Capital Management Lp made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , a net purchase of 833,333 shares made by Robert Lorne Hopfner , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Management Lp made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 1,952 shares made by Julie Jordan , a net sale of 13,037 shares made by Arthur Tzianabos , and a net sale of 7,280 shares made by Paul Alloway .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Management Lp made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.

Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dare Bioscience Inc (DARE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dare Bioscience Inc (DARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dare Bioscience Inc (DARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Management Lp made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Management Lp made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 115,885 shares made by Jean-pierre Sommadossi , a net sale of 17,544 shares made by Bruce Polsky , and a net sale of 15,870 shares made by Maria Arantxa Horga .

In summary, during the past 3 months, insiders sold 57,969 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 57,969 shares. During the past 18 months, 203,467 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 203,467 shares.

Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Management Lp made no insider transaction in Theseus Pharmaceuticals Inc (THRX). Other recent insider transactions involving Theseus Pharmaceuticals Inc (THRX) include a net purchase of 700,000 shares made by Foresite Capital Fund V, L.p. , a net purchase of 479,932 shares made by Carl L Gordon , and a net purchase of 479,932 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Theseus Pharmaceuticals Inc (THRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theseus Pharmaceuticals Inc (THRX) were sold and 1,659,864 shares were bought by its insiders, resulting in a net purchase of 1,659,864 shares.

Theseus Pharmaceuticals Inc (THRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Management Lp made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Management Lp made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,800,000 shares made by Krishna Yeshwant , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 1,514 shares made by Joan Nickerson .

In summary, during the past 3 months, insiders sold 0 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,068 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,932 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Rock Springs Capital Management Lp made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 240,342 shares made by Samuel Kintz , a net sale of 239,847 shares made by Joseph P Lyssikatos , and a net sale of 88,314 shares made by Benjamin Hohl .

In summary, during the past 3 months, insiders sold 183,359 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 183,359 shares. During the past 18 months, 4,855,709 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,855,709 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.